Keywords: ceragennins, show, vitro, angiogenesis, activity, ceragenix, pharmaceuticals

Ceragennins show in vitro angiogenesis activity

Article | 27 March 2006

Ceragenix Pharmaceuticals, a US biopharmaceutical company focused on infectious diseases and dermatology, says that data received from the National Cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in